Pharma Industry Encouraged to Adopt Mobile ePRO for Clinical Trials Efficiency
Exco InTouch, the leading provider of patient engagement and data capture solutions for clinical research and healthcare providers, is championing the industry to adopt mobile electronic Patient Reported Outcomes (ePRO) and other electronic Clinical Outcomes Assessments (eCOA) measures to ensure greater clinical trial success. Currently, over 80% of clinical trials experience delays and mobile ePRO can help mitigate these risks by increasing trial efficiency and patient adherence.
Responding to this issue, Exco InTouch will deliver insights into the application of mobile solutions across the clinical research industry, at this year’s 50th annual DIA meeting, taking place 15–19 June in San Diego.
Showcasing their position as the leader in the application of mobile in ePRO, the company will host on-site demonstrations and a series of 5 presentations, featuring industry-leading content from Tim Davis, CEO, Exco InTouch and Judith Teall, Director of Clinical Excellence. For those looking to learn more about the high value that mobile technology can offer to clinical trials, presentations will include ‘Electronic Clinical Outcome Assessments: Coming to a Device Near You!’ and ‘The Use of Mobile Technology to Place Patients at the Center of Clinical Trials’.
Exco InTouch, which will be exhibiting at booth 2116, will also demonstrate its approach to BYOD (bring your own device) and, more broadly to data capture and patient engagement services across clinical research programs. By enhancing clinical outcomes through improved patient compliance and data capture, their solutions will enhance trial efficiencies, ultimately speeding up potential times to market.
Tim Davis, CEO and co-founder of Exco InTouch commented: “Our presence at the DIA annual meeting will enable us to showcase our strengths as the industry leaders of mobile technology applications within clinical trials and the ease in which our services successfully captures ePRO. We are very much aware of the importance of making the clinical trial process simple for patients, and our technology, which enables a BYOD approach where appropriate, helps further increase patient engagement.”
He continued: “The global pharma industry is increasingly looking at ways to ensure its trials are run on time and with greater adherence. I would encourage everyone who wants to learn more about the benefits of our approach and the instruments and technologies that we have to offer, to visit our booth at DIA (2116) where we would be delighted to demonstrate our services first hand."
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance